The 5 analysts offering 12-month price forecasts for Leap Therapeutics Inc have a median target of 5.00, with a high estimate of 8.00 and a low estimate of 2.50. The median estimate represents a +177.78% increase from the last price of 1.80.
The current consensus among 5 polled investment analysts is to Buy stock in Leap Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.13
Reporting Date Nov 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.